Patrick Wood
Stock Analyst at Morgan Stanley
(3.15)
# 1,147
Out of 5,114 analysts
118
Total ratings
51.11%
Success rate
1.42%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $76 → $83 | $82.75 | +0.30% | 7 | Dec 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $123 → $135 | $127.67 | +5.74% | 3 | Dec 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $17 → $23 | $22.07 | +4.21% | 6 | Dec 2, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $12.03 | -16.87% | 3 | Dec 2, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $56 → $51 | $32.06 | +59.08% | 4 | Dec 2, 2025 | |
| DXCM DexCom | Upgrades: Overweight | $63 → $75 | $66.06 | +13.53% | 10 | Dec 2, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $197 → $210 | $195.59 | +7.37% | 6 | Dec 2, 2025 | |
| BAX Baxter International | Maintains: Underweight | $19 → $15 | $18.96 | -20.89% | 6 | Dec 2, 2025 | |
| BLCO Bausch + Lomb | Upgrades: Overweight | $14 → $21 | $16.98 | +23.67% | 9 | Dec 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $82.89 | -3.49% | 8 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $130 | $95.61 | +35.97% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $84 → $80 | $79.97 | +0.04% | 5 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $276 → $295 | $254.34 | +15.99% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $85.66 | -5.44% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $81.59 | +26.24% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $116.22 | -38.05% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $121.89 | +41.93% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $289.62 | +9.45% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $2.17 | +360.83% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $25.14 | +47.18% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $115.20 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Dec 8, 2025
Maintains: Equal-Weight
Price Target: $76 → $83
Current: $82.75
Upside: +0.30%
TransMedics Group
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $123 → $135
Current: $127.67
Upside: +5.74%
Tandem Diabetes Care
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $17 → $23
Current: $22.07
Upside: +4.21%
RxSight
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $12.03
Upside: -16.87%
PROCEPT BioRobotics
Dec 2, 2025
Maintains: Overweight
Price Target: $56 → $51
Current: $32.06
Upside: +59.08%
DexCom
Dec 2, 2025
Upgrades: Overweight
Price Target: $63 → $75
Current: $66.06
Upside: +13.53%
Becton, Dickinson and Company
Dec 2, 2025
Maintains: Overweight
Price Target: $197 → $210
Current: $195.59
Upside: +7.37%
Baxter International
Dec 2, 2025
Maintains: Underweight
Price Target: $19 → $15
Current: $18.96
Upside: -20.89%
Bausch + Lomb
Dec 2, 2025
Upgrades: Overweight
Price Target: $14 → $21
Current: $16.98
Upside: +23.67%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $82.89
Upside: -3.49%
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $95.61
Upside: +35.97%
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $79.97
Upside: +0.04%
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $254.34
Upside: +15.99%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $85.66
Upside: -5.44%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $81.59
Upside: +26.24%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $116.22
Upside: -38.05%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $121.89
Upside: +41.93%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $289.62
Upside: +9.45%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $2.17
Upside: +360.83%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $25.14
Upside: +47.18%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $115.20
Upside: -